228 related articles for article (PubMed ID: 23325478)
1. MicroRNAs within the continuum of postgenomics biomarker discovery.
Mayr M; Zampetaki A; Willeit P; Willeit J; Kiechl S
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):206-14. PubMed ID: 23325478
[TBL] [Abstract][Full Text] [Related]
2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
Herder C; Karakas M; Koenig W
Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
[TBL] [Abstract][Full Text] [Related]
4. Genetic Architecture of the Cardiovascular Risk Proteome.
Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in cardiovascular diseases: biology and potential clinical applications.
Kartha RV; Subramanian S
J Cardiovasc Transl Res; 2010 Jun; 3(3):256-70. PubMed ID: 20560047
[TBL] [Abstract][Full Text] [Related]
6. Novel methodologies for biomarker discovery in atherosclerosis.
Hoefer IE; Steffens S; Ala-Korpela M; Bäck M; Badimon L; Bochaton-Piallat ML; Boulanger CM; Caligiuri G; Dimmeler S; Egido J; Evans PC; Guzik T; Kwak BR; Landmesser U; Mayr M; Monaco C; Pasterkamp G; Tuñón J; Weber C;
Eur Heart J; 2015 Oct; 36(39):2635-42. PubMed ID: 26049157
[TBL] [Abstract][Full Text] [Related]
7. Precision Medicine, Cardiovascular Disease and Hunting Elephants.
Joyner MJ
Prog Cardiovasc Dis; 2016; 58(6):651-60. PubMed ID: 26902518
[TBL] [Abstract][Full Text] [Related]
8. Early identification of cardiovascular risk using genomics and proteomics.
Kullo IJ; Cooper LT
Nat Rev Cardiol; 2010 Jun; 7(6):309-17. PubMed ID: 20440292
[TBL] [Abstract][Full Text] [Related]
9. Regulatory RNAs and cardiovascular disease - with a special focus on circulating microRNAs.
Dlouhá D; Hubáček JA
Physiol Res; 2017 Apr; 66(Suppl 1):S21-S38. PubMed ID: 28379027
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic biomarkers of cardiovascular disease.
Pedrotty DM; Morley MP; Cappola TP
Prog Cardiovasc Dis; 2012; 55(1):64-9. PubMed ID: 22824111
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine and Personalized Medicine in Cardiovascular Disease.
Currie G; Delles C
Adv Exp Med Biol; 2018; 1065():589-605. PubMed ID: 30051409
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR.
Hardikar AA; Farr RJ; Joglekar MV
J Am Heart Assoc; 2014 Feb; 3(1):e000792. PubMed ID: 24572259
[No Abstract] [Full Text] [Related]
13. Exploring predisposition and treatment response--the promise of genomics.
Pan S; Knowles JW
Prog Cardiovasc Dis; 2012; 55(1):56-63. PubMed ID: 22824110
[TBL] [Abstract][Full Text] [Related]
14. Improved risk stratification in prevention by use of a panel of selected circulating microRNAs.
Keller T; Boeckel JN; Groß S; Klotsche J; Palapies L; Leistner D; Pieper L; Stalla GK; Lehnert H; Silber S; Pittrow D; Maerz W; Dörr M; Wittchen HU; Baumeister SE; Völker U; Felix SB; Dimmeler S; Zeiher AM
Sci Rep; 2017 Jul; 7(1):4511. PubMed ID: 28674420
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases.
Edwards JK; Pasqualini R; Arap W; Calin GA
J Cardiovasc Transl Res; 2010 Jun; 3(3):271-9. PubMed ID: 20560048
[TBL] [Abstract][Full Text] [Related]
16. Clinical validation of genetic markers for improved risk estimation.
Kessler T; Schunkert H
Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):25-32. PubMed ID: 22801067
[TBL] [Abstract][Full Text] [Related]
17. GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS.
Rodríguez A; Pajukanta P
Rev Invest Clin; 2018; 70(5):217-223. PubMed ID: 30307448
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the roles of microRNAs in coronary heart disease via integrative genomic analyses.
Huan T; Rong J; Tanriverdi K; Meng Q; Bhattacharya A; McManus DD; Joehanes R; Assimes TL; McPherson R; Samani NJ; Erdmann J; Schunkert H; Courchesne P; Munson PJ; Johnson AD; O'Donnell CJ; Zhang B; Larson MG; Freedman JE; Levy D; Yang X
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1011-21. PubMed ID: 25657313
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of cardiovascular disease: molecular basis and practical considerations.
Vasan RS
Circulation; 2006 May; 113(19):2335-62. PubMed ID: 16702488
[No Abstract] [Full Text] [Related]
20. A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience.
Kraus WE; Granger CB; Sketch MH; Donahue MP; Ginsburg GS; Hauser ER; Haynes C; Newby LK; Hurdle M; Dowdy ZE; Shah SH
J Cardiovasc Transl Res; 2015 Nov; 8(8):449-57. PubMed ID: 26271459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
